{"result": "(\"entity\"<|>FÁRMACO<|>ORGANIZATION<|>Fármaco refers to a drug or medication that can be absorbed and metabolized in the body.)\n##\n(\"entity\"<|>DIETA<|>ORGANIZATION<|>Dieta refers to the dietary components that can influence the absorption and metabolism of medications.)\n##\n(\"entity\"<|>SALAS BILIARES<|>ORGANIZATION<|>Sales biliares are intestinal secretions that facilitate the dissolution of liposoluble medications.)\n##\n(\"entity\"<|>ALIMENTOS<|>ORGANIZATION<|>Alimentos refer to food components that can affect the pharmacokinetics of drugs.)\n##\n(\"entity\"<|>MARGEN TERAPÉUTICO<|>EVENT<|>Margen terapéutico refers to the range of drug dosages that can treat disease effectively without having toxic effects.)\n##\n(\"entity\"<|>EXCRECIÓN<|>EVENT<|>Excreción refers to the process of eliminating drugs and their metabolites from the body, primarily through the kidneys.)\n##\n(\"entity\"<|>PH<|>ORGANIZATION<|>pH refers to the acidity or alkalinity of a solution, which can influence drug absorption and excretion.)\n##\n(\"relationship\"<|>FÁRMACO<|>DIETA<|>The diet can influence the absorption and metabolism of the drug<|>7)\n##\n(\"relationship\"<|>SALAS BILIARES<|>FÁRMACO<|>Bile salts facilitate the dissolution and absorption of liposoluble medications<|>8)\n##\n(\"relationship\"<|>ALIMENTOS<|>FÁRMACO<|>Food components can affect the pharmacokinetics of drugs<|>7)\n##\n(\"relationship\"<|>MARGEN TERAPÉUTICO<|>FÁRMACO<|>The therapeutic margin is crucial for determining safe and effective drug dosages<|>6)\n##\n(\"relationship\"<|>PH<|>EXCRECIÓN<|>The pH of urine can influence the excretion of drugs and their metabolites<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: absorbida la forma activa (base). El etilsuccinato y el estolato son menos susceptibles al pH ácido que el estearato, por lo que su absorción es mucho más completa y se ve menos influenciada por la presencia de alimentos¹⁰.\n\n4) Aumento de la disolución de un fármaco en algún componente de la dieta, como las grasas: Algunas secreciones intestinales como las sales biliares facilitan la disolución de medicamentos liposolubles y su absorción posterior (griseofulvina y halofantrina).\n\n5) Interacciones por mecanismos de reducción: La interacción más conocida es la de la vitamina C y el hierro, ya que este sólo se absorbe en estado ferroso (Fe2+). El ácido ascórbico tiene carácter reductor, por lo que trasforma el Fe3+ en Fe2+ favoreciendo su absorción.\n---\nTema 44. Interacción entre dieta y fármacos 707\n\n## 3.1.2. Interacciones farmacocinéticas\n\nEste tipo de interacciones son las más frecuentes y también las más difíciles de prever y controlar7. Pueden alterar la farmacocinética normal del fármaco, es decir, las características de su liberación, absorción, distribución, metabolismo y excreción. Por tanto, la acción del medicamento puede sufrir modificaciones, incrementándose, disminuyéndose o retrasándose5. En cuanto a la liberación, la velocidad de disgregación de un fármaco se ve modificada por situaciones fisiológicas de motilidad, secreciones gastrointestinales, pH, las cuales pueden alterarse en función de los alimentos. La interacción farmacocinética más frecuente es la que se produce por alteración del proceso de absorción del fármaco. El yeyuno es el lugar de absorción de la mayoría de los medicamentos, por un mecanismo de difusión pasiva o mediante el empleo de proteínas transportadoras. Esta absorción puede verse modificada en función de los cambios físico-químicos y fisiológicos que se producen en el tracto gastrointestinal dependiendo de la presencia o no de alimentos en él (tabla 1). Los cambios en la cantidad de fármaco absorbido, consecuencia de su administración con alimentos, pueden tener importancia clínica, especialmente en aquellos que presentan un margen terapéutico estrecho. Por ejemplo, la absorción de levodopa se altera con la administración simultánea de alimentos, especialmente de alto contenido proteico, ya que se realiza mediante un transportador de aminoácidos en la pared del enterocito.\n\nEn cuanto a la distribución, los mecanismos de acción por los que se puede alterar la dosis de fármaco son dos: unión a proteínas plasmáticas de un nutriente, desplazando así la unión con el fármaco, y una alimentación inadecuada que provoque un déficit de proteínas plasmáticas. En ambos casos habrá un aumento de la actividad del fármaco, por existir una mayor cantidad de fármaco libre para ejercer su efecto.\n\nLos alimentos también pueden afectar al metabolismo de fármacos. El sistema microsomal hepático es el responsable de la metabolización de muchos fármacos, fundamentalmente a través de las distintas familias enzimáticas del citocromo P450 (especialmente CYP3A4, CYP2D6 y CYP2C19), mediante reacciones de fase I (oxidación, reducción e hidrólisis) y reacciones de fase II (glucuronoconjugación, sulfonación o acetilación), eliminándose posteriormente los productos conjugados por la orina o por las heces. Estas interacciones pueden explicarse por: a) los alimentos aportan los sustratos necesarios para las reacciones de conjugación, b) los alimentos pueden por sí mismos provocar inhibición e inducción de los sistemas enzimáticos, c) los alimentos producen cambios en el flujo espleno-hepático. Compuestos como las furanocumarinas y los flavonoides presentes en el zumo de pomelo son un ejemplo clásico de inhibidores selectivos del CYP3A4 a nivel intestinal que conduce a una inhibición reversible del metabolis-\n\nmo oxidativo de los fármacos sustratos de esta enzima (felodipino, midazolan, ciclosporina, carbamazepina, simvastatina, etc.) pudiéndose ver incrementada su biodisponibilidad hasta alcanzar niveles tóxicos. Ciertos componentes de la dieta, generalmente no nutritivos, pueden actuar como inductores o inhibidores de los sistemas enzimáticos hepáticos y modificar la biodisponibilidad de medicamentos (tabla 1)5. Por último, los alimentos influyen en la excreción de los fármacos. La vía de excreción mayoritaria de fármacos y de sus metabolitos es la renal, siendo su principal modulador el pH de la orina. La influencia de la alimentación depende\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ETILSUCINATO<|>ORGANIZATION<|>Etilsuccinato is a compound that is less susceptible to acidic pH, leading to more complete absorption in the body.)\n##\n(\"entity\"<|>ESTOLATO<|>ORGANIZATION<|>Estolato is a compound that is less susceptible to acidic pH, leading to more complete absorption in the body.)\n##\n(\"entity\"<|>ESTEARATO<|>ORGANIZATION<|>Estearato is a compound that is more susceptible to acidic pH, affecting its absorption.)\n##\n(\"entity\"<|>VITAMINA C<|>PERSON<|>Vitamin C is known for its role in enhancing the absorption of iron by converting it from ferric (Fe3+) to ferrous (Fe2+) state.)\n##\n(\"entity\"<|>HIERRO<|>PERSON<|>Iron is a mineral that is essential for various bodily functions and is absorbed in its ferrous state.)\n##\n(\"entity\"<|>GRISEOFULVINA<|>ORGANIZATION<|>Griseofulvina is a liposoluble medication that requires bile salts for dissolution and absorption.)\n##\n(\"entity\"<|>HALOFANTRINA<|>ORGANIZATION<|>Halofantrina is a liposoluble medication that requires bile salts for dissolution and absorption.)\n##\n(\"entity\"<|>YEYUNO<|>GEO<|>Yeyuno is the part of the small intestine where most medications are absorbed through passive diffusion or transport proteins.)\n##\n(\"entity\"<|>CYP3A4<|>ORGANIZATION<|>CYP3A4 is an enzyme in the cytochrome P450 family responsible for the metabolism of many drugs.)\n##\n(\"entity\"<|>CYP2D6<|>ORGANIZATION<|>CYP2D6 is an enzyme in the cytochrome P450 family that metabolizes various drugs.)\n##\n(\"entity\"<|>CYP2C19<|>ORGANIZATION<|>CYP2C19 is an enzyme in the cytochrome P450 family involved in drug metabolism.)\n##\n(\"relationship\"<|>VITAMINA C<|>HIERRO<|>Vitamin C enhances the absorption of iron by converting it to a more absorbable form<|>8)\n##\n(\"relationship\"<|>GRISEOFULVINA<|>YEYUNO<|>Griseofulvina is absorbed in the yeyuno, aided by bile salts<|>7)\n##\n(\"relationship\"<|>HALOFANTRINA<|>YEYUNO<|>Halofantrina is absorbed in the yeyuno, aided by bile salts<|>7)\n##\n(\"relationship\"<|>CYP3A4<|>GRISEOFULVINA<|>CYP3A4 metabolizes griseofulvina, affecting its bioavailability<|>6)\n##\n(\"relationship\"<|>CYP3A4<|>HALOFANTRINA<|>CYP3A4 metabolizes halofantrina, affecting its bioavailability<|>6)\n##\n(\"relationship\"<|>CYP2D6<|>GRISEOFULVINA<|>CYP2D6 may also play a role in the metabolism of griseofulvina<|>5)\n##\n(\"relationship\"<|>CYP2D6<|>HALOFANTRINA<|>CYP2D6 may also play a role in the metabolism of halofantrina<|>5)\n##\n(\"relationship\"<|>CYP2C19<|>GRISEOFULVINA<|>CYP2C19 may also be involved in the metabolism of griseofulvina<|>5)\n##\n(\"relationship\"<|>CYP2C19<|>HALOFANTRINA<|>CYP2C19 may also be involved in the metabolism of halofantrina<|>5)\n<|COMPLETE|>"}]}